Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy

Mauro Di Pilato*, Edward Y. Kim, Bruno L. Cadilha, Jasper N. Prüßmann, Mazen N. Nasrallah, Davide Seruggia, Shariq M. Usmani, Sandra Misale, Valentina Zappulli, Esteban Carrizosa, Vinidhra Mani, Matteo Ligorio, Ross D. Warner, Benjamin D. Medoff, Francesco Marangoni, Alexandra Chloe Villani, Thorsten R. Mempel

*Corresponding author for this work
133 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science